Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats (2008)
- Authors:
- USP affiliated authors: BENDHACK, LUSIANE MARIA - FCFRP ; GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FCFRP; FORP; FMRP
- DOI: 10.1016/j.atherosclerosis.2007.10.011
- Subjects: HIPERTENSÃO; NEFROPATIAS; PRESSÃO SANGUÍNEA; DOENÇAS VASCULARES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Atherosclerosis
- ISSN: 0021-9150
- Volume/Número/Paginação/Ano: v. 198, n. 2, p. 320-331, 2008
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CASTRO, Michele M.; RIZZI, Elen; FIGUEIREDO-LOPES, Lívia; et al. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis, Co Clare, v. 198, n. 2, p. 320-331, 2008. DOI: 10.1016/j.atherosclerosis.2007.10.011. -
APA
Castro, M. M., Rizzi, E., Figueiredo-Lopes, L., Fernandes, K., Bendhack, L. M., Pitol, D. L., et al. (2008). Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis, 198( 2), 320-331. doi:10.1016/j.atherosclerosis.2007.10.011 -
NLM
Castro MM, Rizzi E, Figueiredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL, Gerlach RF, Tanus-Santos JE. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis. 2008 ; 198( 2): 320-331. -
Vancouver
Castro MM, Rizzi E, Figueiredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL, Gerlach RF, Tanus-Santos JE. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis. 2008 ; 198( 2): 320-331. - Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
- Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings
- Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats
- Increased activity of matrix metalloproteinase-2(MMP-2) induced by reactive oxygen species (ROS) in two-kidney one-clip (2K1C) hypertension
- Evaluation of aortic metalloproteinase-2 (MMP-2) activity in two kidney one clip (2K1C) hypertension rats
- Metalloproteinase inhibition ameliorates hypertension and reverses vascular dysfunction and remodeling in renovascular hypertensive rats
- Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats
- Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability
- Antioxidants effects of doxycycline, an inhibitor of MMPS, ameliorates vascular hypertrophy in 2K1C hypertension
- Influência da inibição de metaloproteinases com doxiciclina nos efeitos da nicotina na pressão de ratos
Informações sobre o DOI: 10.1016/j.atherosclerosis.2007.10.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
